Search Result "Atherogenic ratio"
Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 25 Year: 2014 Page: 2892-2901
Author(s): S. Oravec,A. Dukat,P. Gavornik,M. Kucera,K. Gruber,L. Gaspar,M. Rizzo,P.P. Toth,D.P. Mikhailidis,M. Banach
Blood Atherogenicity as a Target for Anti-atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5954-5962
Author(s): Igor A. Sobenin, Dimitry A. Chistiakov, Yuri V. Bobryshev, Anton Y. Postnov, Alexander N. Orekhov
Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 8 Year: 2017 Page: 1195-1206
Author(s): Veronika A. Myasoedova,Galina A. Ivashinnikova,Igor A. Sobenin,Ekaterina A. Ivanova,Alexander N. Orekhov
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little
Atherogenic Index of Plasma is Associated with Body Fat Level in Type 2 Diabetes Mellitus Patients
Journal: Current Vascular Pharmacology
Volume: 16 Issue: 6 Year: 2018 Page: 589-595
Author(s): Ping Song,Lan Xu,Jin Xu,Hai-qing Zhang,Chun-xiao Yu,Qing-bo Guan,Meng Zhao,Xu Zhang
Adiponectin - A Novel Anti-Atherogenic Factor in the Metabolic Syndrome: Mechanisms of Action and Therapeutic Potential
Journal: Vascular Disease Prevention
Volume: 2 Issue: 2 Year: 2005 Page: 107-114
Author(s): Yehuda Kamari, Irit Avni, Ehud Grossman, Yehonatan Sharabi
Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Journal: Current Rheumatology Reviews
Volume: 17 Issue: 1 Year: 2021 Page: 122-130
Author(s): Nevin Hammam,Noha Abdel-Wahab,Tamer A Gheita
Dual Roles of Adiponectin / Acrp30 In Vivo as an Anti-Diabetic and Anti- Atherogenic Adipokine
Journal: Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume: 3 Issue: 4 Year: 2003 Page: 243-253
Author(s): Toshimasa Yamauchi, Kazuo Hara, Naoto Kubota, Yasuo Terauchi, Kazuyuki Tobe, Philippe Froguel, Ryozo Nagai, Takashi Kadowaki